Skandinaviska Enskilda Banken Ab (Publ) Supernus Pharmaceuticals, Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$27.57 - $32.91 $129,579 - $154,676	-4,700 Reduced 16.85%	23,200 $639,000
Q2 2023 Aug 07, 2023	BUY	$29.91 - $38.73 $834,489 - $1.08 Million	27,900 New	27,900 $840,000
Q4 2020 Feb 11, 2021	SELL	$17.7 - $25.81 $123,900 - $180,670	-7,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$20.2 - $25.05 $141,400 - $175,350	7,000 New	7,000 $146,000
Q1 2020 May 13, 2020	SELL	$14.45 - $24.69 $1.09 Million - $1.85 Million	-75,100 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.93 - $29.13 $83,706 - $122,346	4,200 Added 5.92%	75,100 $1.78 Million
Q3 2019 Nov 08, 2019	SELL	$25.47 - $33.37 $2,547 - $3,336	-100 Reduced 0.14%	70,900 $1.95 Million
Q2 2019 Aug 09, 2019	SELL	$29.96 - $38.87 $290,612 - $377,039	-9,700 Reduced 12.02%	71,000 $2.35 Million
Q1 2019 May 15, 2019	BUY	$32.77 - $41.99 $183,512 - $235,144	5,600 Added 7.46%	80,700 $2.83 Million
Q4 2018 Feb 12, 2019	SELL	$30.84 - $49.51 $67,848 - $108,922	-2,200 Reduced 2.85%	75,100 $2.5 Million
Q3 2018 Nov 05, 2018	BUY	$42.7 - $56.55 $1.12 Million - $1.48 Million	26,200 Added 51.27%	77,300 $3.89 Million
Q2 2018 Aug 14, 2018	SELL	$44.1 - $59.85 $590,940 - $801,990	-13,400 Reduced 20.78%	51,100 $3.06 Million
Q1 2018 Apr 30, 2018	SELL	$37.15 - $46.9 $542,390 - $684,740	-14,600 Reduced 18.46%	64,500 $2.95 Million
Q4 2017 Feb 12, 2018	BUY	$36.4 - $42.6 $2.88 Million - $3.37 Million	79,100	79,100 $3.15 Million

286

60.7M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.14B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.